宜明昂科生物医药技术（上海）股份有限公司（股票代码：01541，股票名称：宜明昂科-B）2026年6月16日公告显示，公司当日于香港联交所场内回购股份16.32万股，约占现有已发行股本的0.0389%。本次回购价格区间为每股3.56港元至3.64港元，总代价为59.25万港元（折合592,494港元）。
回购完成后，公司已发行股本增至419,553,905股，当日库藏股数量相应增加至92.34万股。公司此前于2026年5月28日通过有关股份购回授权，获准回购约4,315.08万股，截至目前合计已回购92.34万股，占授权数量的约0.214%。公司确认本次回购已严格遵守香港联合交易所有限公司证券上市规则及其他相关法律规定。
上述公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.